Professor of Medicine, Wayne State University
Hematology
Dr. Joseph P. Uberti, MD
|
|
Give Review
Doctor Joseph P. Uberti, MD practices Hematology. He studied medicine at Wayne State University School of Medicine. Wayne State University School of Medicine has a rank of 63 in research and a 85 in primary care He received awards:"America's Top Doctors", "America's Top Doctors for Cancer" and "Super Doctor". Dr. Joseph P. Uberti is a published physician. He has 75 papers published. The most current publication "Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of pot..." He accepts all Medicare patients.
Publications
- Geographic access to hematopoietic Cell transplantation services in the United States.
- Targeting Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity.
- Low blood lymphocyte count at 30 days post transplant predicts worse Acute GVHD and survival but not relapse in a large retrospective cohort.
- Incidence, Risk Factors, and Outcome of Cytomegalovirus Viremia and Gastroenteritis in Patients with Gastrointestinal Graft-versus-Host Disease.
- Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT.
- Successful hematopoietic stem Cell collection in patients who fail initial plerixafor mobilization for autologous stem Cell transplant.
- High Incidence of Severe aGVHD with Tacrolimus and Mycophenolate Mofetil in a Large Cohort of Related and Unrelated Allogeneic Transplant Patients.
- Extensive Toxic Epidermal Necrolysis Versus Acute Graft Versus Host Disease After Allogenic Hematopoietic Stem-Cell Transplantation: Challenges in Diagnosis and Manage...
- Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: ...
- Evaluating the effects of lenalidomide induction therapy on peripheral stem Cells collection in patients undergoing autologous stem Cell transplant for multiple myeloma.
- Long-term follow up of patients proceeding to transplant using plerixafor mobilized stem Cells and incidence of secondary myelodysplastic syndrome/AML.
- A Phase I Dose-Escalation Trial of High-Dose Melphalan with Palifermin for Cytoprotection Followed by Autologous Stem Cell Transplantation for Patients with Multiple M...
- Anti-Thymocyte Globulin (Thymoglobulin), Tacrolimus, and Sirolimus as Acute Graft-versus-Host Disease Prophylaxis for Unrelated Hematopoietic Stem Cell Transplantation.
- Melphalan 180 mg/m(2) can be Safely Administered as Conditioning Regimen prior to an Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma Patients with Crea...
- Tacrolimus disposition in the ascitic fluid of a bone marrow transplant patient.
- Endpoints for clinical trials testing treatment of Acute graft-versus-host disease: a joint statement.
- Nonabsorbable corticosteroids use in the treatment of gastrointestinal Graft-versus-host disease.
- Twenty years of unrelated donor hematopoietic Cell transplantation for adult recipients facilitated by the National Marrow Donor Program.
- Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk Acute myelogenous leukemia.
- Pilot trial on the use of etanercept and methylprednisolone as primary treatment for Acute graft-versus-host disease.
- Phase I study of involved-field radiotherapy preceding autologous stem Cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
- Treatment of Chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.
- Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays Acute graft-versus-host disease but does not improve outcome for advanced hematol...
- Large pericardial effusion as a complication in adults undergoing SCT.
- Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia.
- Very late recurrences of Leukemia: why does Leukemia awake after many years of dormancy?
- Clinical applications of rituximab in allogeneic stem Cell transplantation: anti-tumor and immunomodulatory effects.
- Prior rituximab correlates with less Acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell...
- Effect of aprepitant on intravenous tacrolimus disposition in reduced intensity hematopoietic stem Cell transplantation.
- Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem Cell transplantation.
- The role of B Cell depleting therapy in graft versus host disease after allogeneic hematopoietic Cell transplant.
- Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of Acute graft-versus-host disease.
- Long term follow-up of allogeneic stem Cell transplantation in patients with myelodysplastic syndromes using busulfan, cytosine arabinoside, and cyclophosphamide.
- Repeated course of rituximab for treatment of nephrotic syndrome in patients with Chronic GVHD.
- Plerixafor for PBSC mobilisation in Myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA.
- Bronchiolitis obliterans following haematopoietic stem Cell transplantation.
- Optimum use of tacrolimus in the prophylaxis of Graft versus host disease.
- Do negative or positive emotions differentially impact mortality after adult stem Cell transplant?
- Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem Cell transplantation.
- Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem Cell transplantation:...
- West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem Cell transplantation.
- The effect of nucleosides and deoxycoformycin on adenosine and deoxyadenosine inhibition of human lymphocyte activation.
- Human lymphokine activated killer (LAK) Cells suppress generation of allospecific cytotoxic T Cells: implications for use of LAK Cells to prevent graft-versus-host dis...
- Allogeneic bone marrow transplantation in high-risk Myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC).
- Prevention of in vivo alloreactions by adoptive immunotherapy with lymphokine-activated killer Cells.
- A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast Cell line.
- Detection of M-bcr/abl fusion by fluorescence in situ hybridization (FISH) in a case of Ph negative CML.
- Bone marrow transplantation for multiple myeloma: the Wayne State experience.
- Allogeneic bone marrow transplantation in patients with Myelodysplastic syndromes.
- Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous Bladder irri...
- Graft failure in children receiving HLA-mismatched marrow transplants with busulfan-containing regimens.
- Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's Lymphoma.
- Phase I study of alpha-interferon augmentation of cyclosporine-induced Graft versus host disease in recipients of autologous bone marrow transplantation.
- Coactivation with anti-CD28 monoclonal antibody enhances anti-CD3 monoclonal antibody-induced proliferation and IL-2 synthesis in T Cells from autologous bone marrow t...
- Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear Cells from most autologous and allogeneic bone marrow transplant recipient...
- Generation of lymphokine-activated killer cells with veto and natural suppressor activity from patients with Leukemias and lymphomas.
- Preclinical studies using immobilized OKT3 to activate human T Cells for adoptive immunotherapy: optimal conditions for the proliferation and induction of non-MHC-rest...
- Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T Cells from normal donors and autologous bon...
- Busulfan-based regimens and allogeneic bone marrow transplantation in patients with Myelodysplastic syndromes.
- Phase I trial of sequential cyclophosphamide, cyclosporin A, and interferon-alpha in patients with Cancer: attempt to induce autologous graft-versus-host reaction to e...
- Clinical course and outcome of patients with Hodgkin''s Disease who progress after autologous transplantation.
- Tacrolimus and methotrexate for the prophylaxis of Acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies.
- Transplantation in patients with multiple myeloma: a multicenter comparative analysis of peripheral blood stem Cell and allogeneic transplant.
- Tacrolimus: a new agent for the prevention of graft-versus-host disease in hematopoietic stem Cell transplantation.
- Dendritic Cell-based vaccines in the setting of peripheral blood stem Cell transplantation: CD34+ Cell-depleted mobilized peripheral blood can serve as a source of pot...
- Practical considerations in the use of tacrolimus for allogeneic marrow transplantation.
- Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with Chronic graft-versus-host disease.
- Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem Cell transplantation.
- Double dose-intensive chemotherapy with autologous stem Cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literatur...
- Risk factors for anaerobic bloodstream infections in bone marrow transplant recipients.
- Allogeneic stem Cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma.
- Chronic graft-versus-host disease: clinical manifestation and therapy.
- Clinical protocol. Purging of autologous stem Cell sources with bcl-x(s) adenovirus for women undergoing high-dose chemotherapy for stage IV breast carcinoma.
- Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic Cell transplant (HCT) patients.
Schools
Wayne State University School Of Medicine
Wayne St University Affil Hospital
Wayne St University Detroit M C
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Basal Cell Carcinoma
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Super Doctor
Education
-
Wayne State University School of Medicine
Hospital
-
DMC - Detroit Receiving Hospital -
DMC Harper University Hospital
Drug Facts
| NPI NUMBER | 1609813104 | |
| NPPES Provider LastName | UBERTI | |
| NPPES Provider FirstName | JOSEPH | |
| NPPES Provider ZIPCode | 482012013 | |
| NPPES Provider State | MI | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 589.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 1.87 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609813104 |
| Last Name Of The Provider | UBERTI |
| First Name Of The Provider | JOSEPH |
| View All |
Similar Doctors
|
|
Dr. Lawrence G. Lum, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Lawrence E. Flaherty, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Pallavi Jasti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Preetha Ramalingam, MD |
|
|
Dr. Michael S. Simon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan E. Harold, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Doina David, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abhinav Deol, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nazik Hammad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yangmin M. Ning, MD |
|
|
Dr. Indryas L. Woldie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lara Zuberi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jyotinder N. Punia, MD |
|
|
Dr. Hashem Ayyad, MD |
|
|
Dr. Sayeh M. Lavasani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rada Gerbi, MD |
|
|
Dr. Jatin Rana, MD |
|
|
Salman Chaudhry, MB BS |
|
|
George Yaghmour |